Semaglutide Weight Loss Program

FDA-Approved Weight Loss Treatment: Wegovy (Semaglutide)

Semaglutide, the active ingredient in Wegovy, is a game-changer for weight loss. This injectable prescription mimics GLP-1 (glucagon-like peptide-1), a hormone that regulates appetite and blood sugar. It works by blocking Ghrelin—the “hunger hormone”—so you feel fuller, longer.

Originally designed for type 2 diabetes, Semaglutide also helps control blood sugar by stimulating insulin release. The best part? Just one injection per week—no daily pills or multiple doses to keep track of!

If you're looking to commit to the science-backed way to manage weight and hunger, Semaglutide might be the solution. 

• Weight loss
• Lowers blood sugar
• Lowers blood pressure
• Lowers cholesterol 
• Lowers risk of heart disease 

• Weekly, Monthly, Quarterly check-in appointments
• Yearly laboratory levels 
• Pregnancy test initially, if applicable. (This medication is not suitable for pregnant or nursing women)

• Clear your mind
• Maintain adequate protein goals
• Increase your water intake
• Make a list and prep for success
• Set attainable goals
• Eat healthy foods- protein, fiber, fats
• Get moving (in the right direction!)
• Commit to change 

Like all medications, compounded Semaglutide can cause side effects. The most common are gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain and constipation. In some cases, more severe side effects may occur, such as pancreatic inflammation, vision changes or low blood sugar, especially when taken with other diabetes medications.

Semaglutide is not suitable for:

• Individuals with a personal or family history of medullary thyroid carcinoma.
• Those with Multiple Endocrine Neoplasia syndrome type 2.
• Patients with a history of severe gastrointestinal disease, including gastroparesis, as Semaglutide can slow gastric emptying.
• People under 18 years of age, as its safety and efficacy in pediatric patients have not been established.

***It is crucial to discuss all potential risks with a healthcare provider before starting treatment with Semaglutide***